Fig. 7.

Blebbistatin and Y-27632 do not affect ASC morphology of resting parietal cells or responses of parietal cells to histamine. A: resting parietal cells were treated with blebbistatin (50 μM) or Y-27632 (10 μM) for 30 min followed by immunostaining for F-actin, ezrin, and myosin IIB as described in Fig. 2. B: parietal cells were treated with blebbistatin or Y-27632 for 30 min, then stimulated with histamine (100 μM) for 30 min followed by fixation and immunostaining for F-actin, ezrin, and myosin IIB as described in Fig. 2.